News
WARD Phase 3 chronic neutropenia trial in full swing; full enrollment on track for 3Q or 4Q 2025 and top-line data in 2H 2026 ...
Drug approval is unequivocally the linchpin to any drug development effort and, given the role of the US market in the global ...
Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and ...
Enterprises around the world are turning to Microsoft's AI and cloud ecosystem to support projects that will help them navigate unpredictable markets, according to a new research report published ...
Blueprint Medicines Corporation today reported financial results, provided a business update for the first quarter ended March 31, 2025, and provided corporate ...
The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and ...
Best SARMs For Bulking, Cutting, Strength & Muscle Growth Using SARMs to build strength and muscles is a common strategy, but ...
19h
Woman & Home on MSNAnnouncing our 2025 woman&home Hair Awards winners!Looking for the best products to create a good hair day? We’ve tested hundreds of buys to find the best of the best ...
The 3 best testosterone booster supplements for muscle growth are presented by Wolfson Brands. The most compelling reasons ...
PLAINSBORO, NJ, USA I April 30, 2025 I Today, The New England Journal of Medicine (NEJM) published results from part 1 of the ongoing phase 3 ESSENCE ...
WELL Health Technologies Corp., a digital healthcare company focused on positively impacting health outcomes, announced it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results